About
S2Medical AB is a Swedish biomedical technology company listed on Nasdaq, based in Linköping. Founded in 2013, the company specializes in innovative solutions for wound healing, infection control, and cosmeceuticals. S2Medical focuses on developing advanced medical technologies aimed at improving the treatment of burns, chronic wounds, and infections, particularly those caused by multiresistant bacteria. The company’s expertise includes research and development of biomaterials and regenerative medicine. Its product portfolio features technologies like Epiprotect, which creates an optimal healing environment by reducing pain and infection risk while accelerating tissue regeneration. Another key innovation is ADMERCIN, which utilizes antimicrobial peptides to enhance the effectiveness of antibiotics against resistant bacterial strains. S2Medical collaborates with universities and research institutions to ensure its products meet high medical standards, serving healthcare professionals and institutions with evidence-based solutions.
Technologies
Keywords
Company Information
-
Employees 17
-
Founded 2013
-
Annual Revenue $1356000
Location
5 Sunnorpsgatan, Linkoeping, Ostergoetland County, Sweden, 582 73